VADUZ, Liechtenstein, Feb. 18, 2026 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the Year-end Report (Q5 2025) at 15:00 CET on February 25. The Year-end Report (Q4 2025) will be published at 8:00 a.m. CET on the same day.

The presentation will be in English via webcast with teleconference:

If you wish to participate via webcast, please use the following link:

https://implantica.events.inderes.com/q4-report-2025

If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference.

https://events.inderes.com/implantica/q4-report-2025/dial-in

Speakers:

CEO Peter Forsell
CFO Andreas Öhrnberg
Chief Corporate Affairs Officer Nicole Pehrsson

For further information, please contact:
Nicole Pehrsson, Investor Relations
Telephone (CH): +41 43 505 20 57
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company's Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on February 18, 2026 at 12:45 p.m. CET.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop®, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/implantica/r/implantica-presents-the-year-end-report--q4-2025--on-february-25-at-15-00-cet,c4309449

The following files are available for download:


 
 https://mb.cision.com/Main/19732/4309449/3940545.pdf Implantica presents the Year-end Report (Q4 2025) on February 25
                                                          at 15:00 CET

View original content:https://www.prnewswire.co.uk/news-releases/implantica-presents-the-year-end-report-q4-2025-on-february-25-at-1500-cet-302691499.html

Tags

More Like This

Implantica presents the Year-end Report (Q4 2024) on February 14 at 15:00 CET

Implantica presents the third quarter 2025 on October 31 at 15:00 CET

Implantica presents the fourth quarter 2023 on February 16 at 15:00 CET

Implantica presents the first quarter 2025 on May 9 at 15:00 CEST

Implantica presents the second quarter 2025 on August 14 at 15:00 CEST

Implantica presents the third quarter 2024 on November 15 at 15:00 CEST

Implantica presents the first quarter 2024 on May 15 at 15:00 CEST

Implantica presents the second quarter 2024 on August 21 at 15:00 CEST